Copied
 
 
Formål
Formål
Selskabets formål er at drive virksomhed med rådgivning inden for forretningsudvikling.
Sidst opdateret den 25.02.2015 og angivet som gældende fra 11.05.2011 (4737 dage).
Ingen historik.
Status
Virksomhedsstatus
NORMAL.
Sidst opdateret den 25.02.2015 og angivet som gældende fra 08.10.2007 (6048 dage).
Ingen historik.
Branche
Branche
Virksomhedsrådgivning og anden rådgivning om driftsledelse (702200).
Sidst opdateret den 26.12.2007 og angivet som gældende fra 01.01.2008 (5963 dage).
HistorikStartStop
Virksomhedsrådgivning og anden rådgivning om driftsledelse (702200)01.01.2008
Anden virksomhedsrådgivning (741490)08.10.200731.12.2007
Revision
Revisionfravalgt
false.
Sidst opdateret den 11.03.2015 og angivet som gældende fra 08.10.2007 (6048 dage).
Ingen historik.
Revisor
Revisor
RSM DANMARK STATSAUTORISERET REVISIONSPARTNERSELSKAB
Sidst opdateret den 27.03.2017 og angivet som gældende fra 17.03.2017 (2600 dage).
Form
Virksomhedsform
60.
Sidst opdateret den 12.02.2019 og angivet som gældende fra 16.12.2018 (1961 dage).
HistorikStartStop
6016.12.2018
8008.10.200715.12.2018
Kontakt
Kontaktoplysninger
contact@baselifescience.com.
Sidst opdateret den 14.12.2016 og angivet som gældende fra 13.12.2016 (2694 dage).
HistorikStartStop
contact@baselifescience.com13.12.2016
kontakt@innovisor.dk23.10.200712.12.2016
Telefon
Telefonnummer
88202120.
Sidst opdateret den 22.09.2022 og angivet som gældende fra 22.09.2022 (585 dage).
HistorikStartStop
8820212022.09.2022
2724879808.03.202221.09.2022
8820212017.03.202007.03.2022
5066000013.12.201616.03.2020
8820212023.10.200712.12.2016
Navne
Tegningsregel
Tegningsregel
Selskabet tegnes af tre medlemmer af bestyrelsen i forening, af en direktør alene eller af den samlede bestyrelse.
Sidst opdateret den 12.02.2019 og angivet som gældende fra 21.12.2018 (1956 dage).
Fortolkning (3 tegningsmuligheder)
3 bestyrelsesmedlemmer +
1 direktør
bestyrelsen
HistorikStartStop
Selskabet tegnes af tre medlemmer af bestyrelsen i forening, af en direktør alene eller af den samlede bestyrelse21.12.2018
Selskabet tegnes af to direktører i forening11.05.201120.12.2018
Ansatte
29.04.2024
Kapital
29.04.2024
Fra årsrapport
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:RSM Danmark, Statsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:25492145
Beskrivelse af revisor:statsautoriseret revisor
Virksomhedens regnskabsklasse:Regnskabsklasse C, mellemstor virksomhed
Grundlag for konklusion (revision):Basis for Opinion We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the “Auditor’s Responsibilities for the Audit of the Consolidated Financial Statements and the Parent Company Financial Statements” section of our report. We are independent of the Group in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):We have audited the consolidated financial statements and the parent company financial statements of BASE life science A/S for the financial year 1 July 2022 to 30 June 2023, which comprise a summary of significant accounting policies, income statement, balance sheet, statement of changes in equity and notes for both the Group the Parent Company, as well as consolidated statement of cash flows. The consolidated financial statements and the parent company financial statements are prepared under the Danish Financial Statements Act. In our opinion, the consolidated financial statements and the parent company financial statements give a true and fair view of the financial position of the Group and the Parent Company at 30 June 2023, and of the results of the Group and the Company's operations as well as the consolidated cash flows for the financial year 1 July 2022 - 30 June 2023 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on Management’s Review Management is responsible for Management’s Review. Our opinion on the consolidated financial statements and the parent company financial statements døs not cover Management’s Review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the consolidated financial statements and the parent company financial statements, our responsibility is to read Management’s Review and, in doing so, consider whether Management’s Review is materially inconsistent with the consolidated financial statements and the parent company financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether Management’s Review provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that Management’s Review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statement Act. We did not identify any material misstatement of Management’s Review.
Bibranche
Ingen nuværende registrering.
Ingen historik.
Børsnoteret
29.04.2024
Ingen nuværende registrering.
Ingen historik.
Hjemmeside
29.04.2024
Hjemmeside
www.baselifescience.com.
Sidst opdateret den 14.12.2016 og angivet som gældende fra 13.12.2016 (2694 dage).
Ingen historik.